Multi-cohort Phase 1b study evaluating NTR-1011, a first-in-class DNASE1L3 fusion protein designed to degrade Neutrophil Extracellular Traps ...

U.S. children and adolescents see thousands of food marketing messages on digital media platforms each year, according to new ...

Adds a once-daily, oral therapy candidate for eosinophilic esophagitis with FDA Orphan Drug and Fast Track Designations –– ABO-801 acquired for ...

Religious Life Faith Break Mondays will take place Nov. 9 at 12:15 p.m. in University Center 2205. Faith Break Mondays is a ...

A Virginia boy has been named TIME’s Kid of the Year thanks to his role in helping first responders better comfort children ...

Ghana has earmarked 685 million cedis ($58.5 million) for coastal protection under the WACA program. The project includes breakwaters, beach restoration, and measures to protect coastal communities.

The State Department announced a $20 million reward for information on Iran's nuclear facilities, equipment and personnel.

Perry VanKirk Career Academy is accepting registrations for its spring Emergency Medical Technician (EMT) Academy, providing ...

The World Bank has approved $500 million in additional funding for Nigeria's Agro-Climatic Resilience in Semi-Arid Landscapes (ACReSAL) project, targeting 6.6 million beneficiaries by 2031. Land ...

CLEVELAND, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today reported third-quarter 2026 financial results and provided an update on the commercial launch of ZEVASKYN.

<?xml encoding="utf-8" ?> CarGurus CARG reported third-quarter financial results on Thursday. The transcript from the company ...

Abeona Therapeutics Inc. announced the acquisition of APT-1011 (now ABO-801), a product candidate for eosinophilic esophagitis (EoE), from Ellodi Pharmaceuticals, and entered into a securities ...